Business Standard

India likely to get Omicron-specific vaccine by year-end, says SII chief

SII is working with Novavax to bring the Omicron-specific vaccine, as the nation continues to record a surge in the number of Covid-19 cases

Adar Poonawalla
Premium

Adar Poonawalla (Photo: Kamlesh Pednekar)

BS Web Team
The Serum Institute of India (SII) is currently working on an Omicron-specific vaccine, which is expected to be launched by the end of the year, said CEO Adar Poonawalla said on Monday.

Serum Institute is working with Novavax to bring the Omicron-specific vaccine, as India continues to record a surge in the number of Covid-19 cases. The new vaccine will be "specific to the BA5 sub-variant of Omicron, for which the UK has approved an updated Moderna vaccine. The bivalent vaccine targets the Omicron variant as well as the original form," NDTV reported.

Also Read: What is Chikungunya?

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in